Infectious Diseases (except HIV/AIDS)
Showing page 190 of 716 pages of list content
-
SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3 rd mRNA Vaccine Dose
This article's authors -
SARS-CoV-2 Seroprevalence among health care workers after the first and second pandemic wave
This article's authors -
Development of a COVID-19 risk-assessment model for participants at an outdoor music festival: Evaluation of the validity and control measure effectiveness
This article's authors -
Different forms of superspreading lead to different outcomes: heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2
This article's authors -
Immunogenicity and Safety of Booster Dose of S-268019-b or Tozinameran in Japanese Participants: An Interim Report of Phase 2/3, Randomized, Observer-Blinded, Noninferiority Study
This article's authors -
Spike mutations of the SARS-CoV-2 Omicron: more likely to occur in the epitopes
This article's authors -
Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac and ChAdOx1 and BNT162b2 plus heterologous BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults
This article's authors -
Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2
This article's authors -
Precision recruitment for high-risk participants in a COVID-19 research study
This article's authors -
Prevalence of Bacterial Coinfection and Patterns of Antibiotics Prescribing in Patients with COVID-19: A Systematic review and Meta-Analysis
This article's authors